Excessive sweating that soaks your bed sheets, especially noticed in the morning, can be a lesser-known warning sign of ...

A groundbreaking study from Brown University Health researchers has identified a crucial factor that may help improve treatment for glioblastoma, one of the most aggressive and common forms of adult ...

PrECOG, LLC, today announced the publication of final results from the pivotal phase 3 PATINA study in the New England ...

Peart S. Virginia Tech-developed H-FIRE treatment now offered at Equine Medical Center. Virginia Tech News. January 29, 2026. Accessed January 30, 2026. https://news.vt.edu/articles/2026/01/vetmed-emc ...

This years 2026 ASCO Gastrointestinal Cancers Symposium was packed with practice-shaping data across colorectal and upper ...

Inqovi for AML treatment ...

The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after ...

SCAC, while rare, is primarily driven by the human papillomavirus (HPV) and accounts for about 85% of all anal cancers. There ...

The FDA accepted the BLA for ivonescimab plus chemotherapy for patients with EGFR-mutated non-small cell lung cancer post-TKI ...

Ivonescimab's BLA acceptance is a milestone for PD-1/VEGF bispecific antibodies in the U.S., potentially transforming ...

The FDA is currently reviewing Summit's PD-1/VEGF bispecific as part of a chemotherapy combo for the treatment of locally advanced or metastatic non-squamous non-small cell lung cancer.

A stage four breast cancer patient is speaking out against the Kaiser Permanente strike, which has disrupted her treatment, ...